Influenza: Addressing the Burden Through New Therapeutic Options

Event Information

Share this event

Date and Time

Location

Location

Marriott Marquis Washington, DC

901 Massachusetts Ave NW

Liberty Salons IJKL; Meeting Level 4

Washington, DC 20001

View Map

Event description

Description


This program is intended for IDWeek™ 2019 attendees only.



Activity Chair

Michael G. Ison, MD, MS, FIDSA, FAST
Professor, Divisions of Infectious Diseases and Organ Transplantation
Northwestern University Feinberg School of Medicine
Medical Director, Transplant and Immunocompromised Host Infectious Diseases Service
Northwestern University Comprehensive Transplant Center
Chicago, IL

Faculty

William A. Fischer II, MD
Assistant Professor of Medicine
Division of Pulmonary Diseases and Critical Care Medicine
Institute of Global Health and Infectious Diseases
University of North Carolina School of Medicine
Chapel Hill, NC

Andrew T. Pavia, MD, FAAP, FIDSA
George and Esther Gross Presidential Professor
Chief, Division of Pediatric Infectious Diseases
University of Utah
Director, Hospital Epidemiology Program
Primary Children's Hospital
Salt Lake City, UT


Overview

Influenza places a substantial burden on the health of people in the United States each year. The Centers for Disease Control and Prevention estimates that influenza has caused between 9.2 million and 35.6 million illnesses, between 140,000 and 710,000 hospitalizations, and between 12,000 and 56,000 deaths annually since 2010. As such, there is an unmet need for better diagnostic and treatment modalities. Antivirals with different targets and different mechanisms of action provide multiple therapeutic options and hold promise in improving treatment effectiveness. In this educational activity, expert physicians will discuss the diagnosis, epidemiology, and treatment of influenza.



Agenda

6:00 PM
Registration and Dinner

6:30 PM
Introduction and Pretest
Michael G. Ison, MD, MS, FIDSA, FAST

6:35 PM
Recent and Emerging Advances in Influenza Management: What’s New in 2019?
Michael G. Ison, MD, MS, FIDSA, FAST

7:05 PM
Challenging Case 1: Testing for and Diagnosing Influenza in the Hospitalized Patient
Andrew T. Pavia, MD, FAAP, FIDSA

7:20 PM
Question and Answer
Michael G. Ison, MD, MS, FIDSA, FAST

7:25 PM
Challenging Case 2: Treating Influenza in Patients at Normal Risk for Complications
William A. Fischer II, MD

7:40 PM
Question and Answer
Michael G. Ison, MD, MS, FIDSA, FAST

7:45 PM
Challenging Case 3: Treating Influenza in Patients at High Risk for Complications – 75-Year-Old Patient
William A. Fischer II, MD

8:00 PM
Challenging Case 4: Treating Influenza in Patients at High Risk for Complications – 16-Year-Old Diabetic Patient
Andrew T. Pavia, MD, FAAP, FIDSA

8:15 PM
Posttest and Question & Answer
Michael G. Ison, MD, MS, FIDSA, FAST

8:30 PM
Conclusion



Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Apply revised guidelines into practice regarding the diagnosis of influenza in the hospitalized patient, to improve earlier detection and treatment.

  • Differentiate currently available treatments for influenza based on their efficacy, effect on duration of virus, as well as the ability to improve outcomes for patients at normal and high risk for complications.

  • Incorporate therapeutic regimens into practice for prophylaxis, prevention, as well as treatment of influenza, to reduce the duration of illness, viral shedding, and complications associated with the disease.



Target Audience

The intended audience for this activity is infectious disease specialists and other health care professionals involved in the management of patients with influenza.



This continuing medical education activity is provided by Vindico Medical Education.

This activity is supported by an educational grant from Genentech, Inc.

This activity is not affiliated with the official program of IDWeek™ 2019.

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

Faculty, topics, program schedule, and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program committee.

MIPS Qualifying Activity:
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Participants who successfully complete the activity and its performance assessment will receive printable documentation of successful completion for MIPS self-reporting.

Date and Time

Location

Marriott Marquis Washington, DC

901 Massachusetts Ave NW

Liberty Salons IJKL; Meeting Level 4

Washington, DC 20001

View Map

Save This Event

Event Saved